Loading...

AVROBIO, Inc.

AVRO•NASDAQ
Healthcare
Biotechnology
$1.40
$-0.02(-1.41%)

AVROBIO, Inc. (AVRO) Stock Overview

Explore AVROBIO, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.9/100

Key Financials

Market Cap5.2M
P/E Ratio-0.36
EPS (TTM)$8.28
ROE-0.35%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.37

AVRO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AVROBIO, Inc. (AVRO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.36 and a market capitalization of 5.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;